nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00331	0.00331	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—PENK—narcolepsy	0.00324	0.00324	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00318	0.00318	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00317	0.00317	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00307	0.00307	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00301	0.00301	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.003	0.003	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00299	0.00299	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00298	0.00298	CbGpPWpGaD
Solifenacin—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00298	0.00298	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00295	0.00295	CbGpPWpGaD
Solifenacin—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00295	0.00295	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—TRH—narcolepsy	0.00287	0.00287	CbGpPWpGaD
Solifenacin—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Solifenacin—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00279	0.00279	CbGpPWpGaD
Solifenacin—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00278	0.00278	CbGpPWpGaD
Solifenacin—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00278	0.00278	CbGpPWpGaD
Solifenacin—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00277	0.00277	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—TRH—narcolepsy	0.00275	0.00275	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00274	0.00274	CbGpPWpGaD
Solifenacin—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00263	0.00263	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00262	0.00262	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HCRTR2—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HCRTR1—narcolepsy	0.00261	0.00261	CbGpPWpGaD
Solifenacin—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0026	0.0026	CbGpPWpGaD
Solifenacin—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Solifenacin—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00256	0.00256	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—P2RY11—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—HRH3—narcolepsy	0.00252	0.00252	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HCRTR1—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HCRTR2—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—P2RY11—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—HRH3—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Solifenacin—CHRM5—G alpha (q) signalling events—HTR2A—narcolepsy	0.00238	0.00238	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HCRTR2—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HCRTR1—narcolepsy	0.00237	0.00237	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—P2RY11—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HCRTR1—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HCRTR2—narcolepsy	0.00227	0.00227	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.00225	0.00225	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0022	0.0022	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.00219	0.00219	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HCRT—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Solifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00213	0.00213	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—TAC1—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—NPS—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.002	0.002	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.002	0.002	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HCRT—narcolepsy	0.00195	0.00195	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00194	0.00194	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00193	0.00193	CbGpPWpGaD
Solifenacin—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—PENK—narcolepsy	0.00191	0.00191	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.00186	0.00186	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Solifenacin—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00184	0.00184	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.00183	0.00183	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00176	0.00176	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00174	0.00174	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—PENK—narcolepsy	0.00173	0.00173	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00169	0.00169	CbGpPWpGaD
Solifenacin—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Solifenacin—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Solifenacin—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00165	0.00165	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—TRH—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.0016	0.0016	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Solifenacin—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00158	0.00158	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.00155	0.00155	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Solifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Solifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—TRH—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00143	0.00143	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HRH3—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HCRTR1—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HCRTR2—narcolepsy	0.0014	0.0014	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—P2RY11—narcolepsy	0.00135	0.00135	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.00134	0.00134	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Solifenacin—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0013	0.0013	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Solifenacin—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HRH3—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Solifenacin—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CHKB—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Solifenacin—CHRM4—GPCR ligand binding—HTR2A—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Solifenacin—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.0012	0.0012	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—TAC1—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—NPS—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00117	0.00117	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HCRT—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—NPS—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Solifenacin—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Solifenacin—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00111	0.00111	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HCRT—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Solifenacin—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—NPS—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—TAC1—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—TAC1—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—NPS—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PENK—narcolepsy	0.00102	0.00102	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.000994	0.000994	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.000991	0.000991	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.000981	0.000981	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PENK—narcolepsy	0.000981	0.000981	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00096	0.00096	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.000957	0.000957	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.000947	0.000947	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000943	0.000943	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000943	0.000943	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00094	0.00094	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00094	0.00094	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.000931	0.000931	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.000931	0.000931	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.000911	0.000911	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.000908	0.000908	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.0009	0.0009	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.000872	0.000872	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TRH—narcolepsy	0.000871	0.000871	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.000869	0.000869	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—CPT1B—narcolepsy	0.000868	0.000868	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.00086	0.00086	CbGpPWpGaD
Solifenacin—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000847	0.000847	CbGpPWpGaD
Solifenacin—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.000844	0.000844	CbGpPWpGaD
Solifenacin—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.000836	0.000836	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TRH—narcolepsy	0.000834	0.000834	CbGpPWpGaD
Solifenacin—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000824	0.000824	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000795	0.000795	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000795	0.000795	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.000793	0.000793	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.000793	0.000793	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000785	0.000785	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000785	0.000785	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000775	0.000775	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.000772	0.000772	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000765	0.000765	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HRH3—narcolepsy	0.000764	0.000764	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HRH3—narcolepsy	0.000731	0.000731	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000722	0.000722	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000722	0.000722	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.00072	0.00072	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.00072	0.00072	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000713	0.000713	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000713	0.000713	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—HTR2A—narcolepsy	0.00071	0.00071	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PENK—narcolepsy	0.000691	0.000691	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PENK—narcolepsy	0.000688	0.000688	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000682	0.000682	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	0.00068	0.00068	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HTR2A—narcolepsy	0.000644	0.000644	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—NPS—narcolepsy	0.000633	0.000633	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TAC1—narcolepsy	0.000633	0.000633	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	0.000617	0.000617	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—NPS—narcolepsy	0.000606	0.000606	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TAC1—narcolepsy	0.000606	0.000606	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000587	0.000587	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TRH—narcolepsy	0.000585	0.000585	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TRH—narcolepsy	0.00058	0.00058	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000515	0.000515	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000513	0.000513	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000508	0.000508	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CHKB—narcolepsy	0.000499	0.000499	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000478	0.000478	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000477	0.000477	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000472	0.000472	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000434	0.000434	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000433	0.000433	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.000429	0.000429	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000427	0.000427	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000427	0.000427	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000425	0.000425	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000425	0.000425	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000421	0.000421	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000421	0.000421	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HTR2A—narcolepsy	0.000381	0.000381	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HTR2A—narcolepsy	0.000365	0.000365	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000339	0.000339	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000257	0.000257	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000256	0.000256	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000253	0.000253	CbGpPWpGaD
